ReviewPharmacoEconomics2022

Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Thomas Otten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.